CD40LG and rheumatoid arthritis: At this cut-off we observed that 16.4% of the RA patients were positive for IgM anti-CarP antibodies, while 49.2% and 40.8% were positive for IgG (part of the results from Shi et al. [6]) and IgA (Fig. 1a).